Literature DB >> 15098719

Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors.

Koji Tada1, Kimihiro Kasamo, Tadashi Suzuki, Yamato Matsuzaki, Takuya Kojima.   

Abstract

This study examines the activity of hippocampal CA, pyramidal neurons during conditioned fear stress (CFS)-induced freezing behavior in unanesthetized, unrestrained rats. The firing frequency of hippocampal CA1 pyramidal neurons was significantly decreased when conditioned rats exhibited freezing behavior. Firing frequency returned to the baseline after freezing behavior disappeared. The selective 5-hydroxytryptamine (5-HT)1A antagonists, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide (WAY-100635), and N-tert-butyl-3-[4-(2-methoxyphenyl)piperazine-1-yl]-2-phenylpropamide (WAY-100135) and 5-HT depletion with parachlorophenylalanine (PCPA) completely abolished the decrease in firing frequency during CFS-induced freezing behavior. These results suggested that endogenous 5-HT inhibited the firing activity of hippocampal CA1 pyramidal neurons during CFS-induced freezing behavior mainly through stimulating 5-HT1A receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098719     DOI: 10.1002/hipo.10178

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  12 in total

1.  Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress.

Authors:  Machiko Matsumoto; Kaori Tachibana; Hiroko Togashi; Kazue Tahara; Taku Kojima; Taku Yamaguchi; Mitsuhiro Yoshioka
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

2.  Amygdalar stimulation produces alterations on firing properties of hippocampal place cells.

Authors:  Eun Joo Kim; Earnest S Kim; Mijeong Park; Jeiwon Cho; Jeansok J Kim
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

3.  Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.

Authors:  Xujiao Zhou; Rong Zhang; Shenghai Zhang; Jihong Wu; Xinghuai Sun
Journal:  J Neurosci       Date:  2018-12-12       Impact factor: 6.167

Review 4.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

5.  Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology.

Authors:  L Ciranna
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

6.  Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces.

Authors:  Roshan Cools; Andy J Calder; Andrew D Lawrence; Luke Clark; Ed Bullmore; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

Review 7.  Using the conditioned fear stress (CFS) animal model to understand the neurobiological mechanisms and pharmacological treatment of anxiety.

Authors:  Xiaobai Li
Journal:  Shanghai Arch Psychiatry       Date:  2012-10

Review 8.  What Do We Really Know About 5-HT1A Receptor Signaling in Neuronal Cells?

Authors:  Paulina S Rojas; Jenny L Fiedler
Journal:  Front Cell Neurosci       Date:  2016-11-24       Impact factor: 5.505

Review 9.  Serotonergic modulation of conditioned fear.

Authors:  Judith R Homberg
Journal:  Scientifica (Cairo)       Date:  2012-10-09

Review 10.  Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function.

Authors:  Elena Dale; Alan L Pehrson; Theepica Jeyarajah; Yan Li; Steven C Leiser; Gennady Smagin; Christina K Olsen; Connie Sanchez
Journal:  CNS Spectr       Date:  2015-09-08       Impact factor: 3.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.